Prevalence of Helicobacter pylori resistant to clarithromycin, metronidazole and amoxicillin isolated from pediatric patients in China

Background: Antimicrobial resistance in Helicobacter pylori (H. pylori) is an increasing serious problem, and the development of methods for detecting the resistance and the constant surveillance of both prevalence and evolution of H. pylori resistance in children would greatly improve the selection of antibiotics used to treat gastroduodenal infection with this organism. This study was designed to investigate the prevalence of H. pylori resistance to clarithromycin, metronidazole and amoxicillin isolated from pediatric patients in China. Methods: A total of 44 H. pylori isolates from pediatric patients with gastritis and peptic ulcer undergoing endoscopy were cultured during the period of October 2002 to November 2003 at Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China. The susceptibilities of the 44 H. pylori isolated strains to clarithromycin, metronidazole and amoxicillin were tested by the agar dilution test to determine the minimum inhibitory concentration (MIC). Results: The range of MIC was as follows: clarithromycin 0.125-64 μg/ml; metronidazole <0.125-128 μg/ml; and amoxicillin <0.125-64 μg/ml. The rate of H. pylori resistant to clarithromycin, metronidazole and amoxicillin in the children was 18.2% (8 strains), 31.8% (14 strains) and 9.1% (4 strains), respectively. Three strains (6.8%) were simultaneously resistant to the 3 antibiotics. Conclusions: The prevalence of H. pylori resistance to metronidazole is high in children, and the rate of resistance to clarithromycin is higher than that in adults. Amoxicillin-resistant strains are found, and multidrug-resistant strains of H. pylori to clarithromycin, metronidazole and amoxicillin are also found. World J Pediatr 2006;1:49-52

[1]  M. Garnier,et al.  T2182C Mutation Is Not Associated with Clarithromycin Resistance in Helicobacter pylori , 2005, Antimicrobial Agents and Chemotherapy.

[2]  M. Asaka,et al.  In vitro induction of resistance to metronidazole, and analysis of mutations in rdxA and frxA genes from Helicobacter pylori isolates , 2005, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[3]  Fernando García,et al.  Comparison of E-test and disk diffusion assay to evaluate resistance of Helicobacter pylori isolates to amoxicillin, clarithromycin, metronidazole and tetracycline in Costa Rica. , 2004, International journal of antimicrobial agents.

[4]  J. Sultana,et al.  T2182C Mutation in 23S rRNA Is Associated with Clarithromycin Resistance in Helicobacter pylori Isolates Obtained in Bangladesh , 2004, Antimicrobial Agents and Chemotherapy.

[5]  F. Kaneko,et al.  High prevalence rate of Helicobacter pylori resistance to clarithromycin during long‐term multiple antibiotic therapy for chronic respiratory disease caused by non‐tuberculous mycobacteria , 2004, Alimentary pharmacology & therapeutics.

[6]  Yong Liu,et al.  New mutation points in 23S rRNA gene associated with Helicobacter pylori resistance to clarithromycin in northeast China. , 2004, World journal of gastroenterology.

[7]  Farahnaz Nariman,et al.  Susceptibilities to Different Antibiotics of Helicobacter pylori Strains Isolated from Patients at the Pediatric Medical Center of Tehran, Iran , 2004, Journal of Clinical Microbiology.

[8]  S. Raptis,et al.  Factors that May Affect Treatment Outcome of Triple Helicobacter pylori Eradication Therapy with Omeprazole, Amoxicillin, and Clarithromycin , 2004, Digestive Diseases and Sciences.

[9]  F. Mégraud,et al.  Characterization of the genes rdxA and frxA involved in metronidazole resistance in Helicobacter pylori. , 2003, Research in microbiology.

[10]  岡本 健志 A change in PBP1 is involved in amoxicillin resistance of clinical isolates of Helicobacter pylori , 2003 .

[11]  Toshiaki Shimizu,et al.  Antibiotic Resistance of Helicobacter pylori Strains in Japanese Children , 2002, Journal of Clinical Microbiology.

[12]  K. Dzierżanowska-Fangrat,et al.  Primary resistance to clarithromycin in clinical strains of Helicobacter pylori isolated from children in Poland. , 2001, International journal of antimicrobial agents.

[13]  G. Perez-Perez,et al.  Increasing Multidrug Resistance inHelicobacter pylori Strains Isolated from Children and Adults in Mexico , 2001, Journal of Clinical Microbiology.

[14]  J. Cabrita,et al.  Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999). , 2000, The Journal of antimicrobial chemotherapy.

[15]  I. Mitov,et al.  Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria. , 2000, Journal of medical microbiology.

[16]  R. Spiller,et al.  Antimicrobial Susceptibility Testing ofHelicobacter pylori in a Large Multicenter Trial: the MACH 2 Study , 1999, Antimicrobial Agents and Chemotherapy.

[17]  R. Spiller,et al.  The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. , 1999, Gastroenterology.

[18]  A. Sepulveda,et al.  Amoxycillin tolerance in Helicobacter pylori. , 1999, The Journal of antimicrobial chemotherapy.

[19]  F. Bazzoli,et al.  Therapy of H. pylori infection. , 1997, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[20]  J. Versalovic,et al.  Identification of a 23S rRNA Gene Mutation in Clarithromycin‐Resistant Helicobacter pylori , 1996, Helicobacter.

[21]  D. Graham,et al.  Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori , 1996, Antimicrobial agents and chemotherapy.